Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel

BACKGROUND AND OBJECTIVES: Resistance to the antiplatelet treatment with clopidogrel has both genetic and non-genetic causes. Polymorphic variants of cytochrome P450 3A4 isoenzyme involved in the bioactivation of clopidogrel might have an influence on responsiveness to the drug. The aim of this stud...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur J Drug Metab Pharmacokinet
Egile Nagusiak: Danielak, Dorota, Karaźniewicz-Łada, Marta, Wiśniewska, Karolina, Bergus, Piotr, Burchardt, Paweł, Komosa, Anna, Główka, Franciszek
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2016
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5306247/
https://ncbi.nlm.nih.gov/pubmed/26891871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-016-0324-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak